Deutsche Bank Ag\ Age X Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$0.79 - $1.52 $869 - $1,672	-1,100 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.68 - $1.13 $4,004 - $6,654	-5,889 Reduced 84.26%	1,100 $1,000
Q1 2020 May 14, 2020	SELL	$0.78 - $1.95 $340 - $850	-436 Reduced 5.87%	6,989 $6,000
Q4 2019 Feb 14, 2020	BUY	$1.25 - $1.82 $1,828 - $2,662	1,463 Added 24.54%	7,425 $12,000
Q3 2019 Nov 14, 2019	SELL	$1.96 - $3.38 $19,707 - $33,985	-10,055 Reduced 62.78%	5,962 $10,000
Q2 2019 Aug 14, 2019	BUY	$2.58 - $4.92 $12,799 - $24,408	4,961 Added 44.87%	16,017 $58,000
Q1 2019 May 15, 2019	SELL	$3.0 - $4.85 $5,214 - $8,429	-1,738 Reduced 13.58%	11,056 $44,000
Q4 2018 Feb 14, 2019	BUY	$2.49 - $5.5 $31,857 - $70,367	12,794 New	12,794 $37,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.